Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.

Eligibility criteria

Qualifiers

Adults (>18 years old).

Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.

Scheduled pneumonectomy or lobectomy.

Admission to a conventional surgical unit postoperatively.

Disqualifiers

History of atrial fibrillation.

Requirement for telemetry for AV block or tachyarrhythmias (>140 bpm).

Dependency on a pacemaker.

Participation in another interventional clinical trial affecting POAF incidence.

Trial design

Treatments tested in this trial

  • smartwatch
  • ECG

Treatment groups

302 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Clinique Victor Pauchet

Collaborator